Zimmer Biomet Holdings, Inc. (ZBH)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Zimmer Biomet Holdings, Inc. (ZBH)

Go deeper and ask any question about ZBH

Company Performance

Current Price

as of Oct 02, 2024

$105.69

P/E Ratio

22.38

Market Cap

$21.86B

Description

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.

Metrics

Overview

  • HQWarsaw, IN
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerZBH
  • Price$105.69-1.54%

Trading Information

  • Market Cap$21.86B
  • Float99.86%
  • Average Daily Volume (1m)1,748,155
  • Average Daily Volume (3m)1,462,308
  • EPS$4.82

Company

  • Revenue$7.52B
  • Rev Growth (1yr)3.87%
  • Net Income$242.80M
  • Gross Margin60.69%
  • EBITDA Margin29.80%
  • EBITDA$578.70M
  • EV$27.82B
  • EV/Revenue3.70
  • P/E22.38
  • P/S2.94